Replicating Vaccines : A New Generation /

Technological advances, together with a better understanding of the molecular biology of infectious microorganisms, are creating exciting possibilities for a new generation of replicating vaccines. Historically, live vaccines have been either directly derived from a natural source or attenuated by e...

Full description

Saved in:
Bibliographic Details
Other Authors: Dormitzer, Philip R. (Editor), Mandl, Christian W. (Editor), Rappuoli, Rino (Editor)
Format: Electronic eBook
Language:English
Published: Basel : Springer Basel, 2011.
Edition:First.
Series:Birkhäuser advances in infectious diseases.
Subjects:
Online Access:Connect to this title online

MARC

LEADER 00000nam a22000005i 4500
001 b3075753
003 CStclU
005 20240627104205.0
006 m o d
007 cr |||||||||||
008 101109s2011 sz | o |||| 0|eng d
020 |a 9783034602778 
024 7 |a 10.1007/978-3-0346-0277-8  |2 doi 
035 |a (DE-He213)spr978-3-0346-0277-8 
040 |d UtOrBLW 
050 4 |a QR46 
245 0 0 |a Replicating Vaccines :  |b A New Generation /  |c edited by Philip R. Dormitzer, Christian W. Mandl, Rino Rappuoli. 
250 |a First. 
264 1 |a Basel :  |b Springer Basel,  |c 2011. 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Birkhäuser Advances in Infectious Diseases 
505 0 |a SECTION 1: Today’s Live Attenuated Vaccines -- Live Vaccines and their Role in Modern Vaccinology -- Live Attenuated Vaccines: Influenza, Rotavirus and Varicella Zoster -- Classical Live Viral Vaccines -- SECTION 2: Genetically Attenuated Micro-Organisms as Vaccines -- Recombinant Live Vaccines to Protect Against the Severe Acute Respiratory Syndrome Coronavirus -- Live Attenuated Shigella Vaccines. Is encouraging good enough? -- New generation BCG vaccines -- SECTION 3: Manipulating Host-Pathogen Interactions to Make Vaccines -- Basic Science Paves the Way to Novel Safe and Effective Pestivirus Vaccines -- Live Attenuated Influenza Virus Vaccines: NS1 Truncation as an Approach to Virus Attenuation Approaches -- An Attenuated Herpes implex Virus 1 Live Virus Vaccine Candidate that is Replication Competent but Defective in Epithelial Cell to Cell and Neuronal Spread -- RSV Deletion Mutant – Innate Immunity -- Live Attenuated Cholera Vaccines: Flagella and Reactogenicity -- SECTION 4: New Types of Replicating Vaccines -- Replication-defective Herpes simplex Virus Mutant Strains as Genital Herpes Vaccines and Vaccine Vectors -- Nucleic Acid-Based Infectious and Pseudo-Infectious Flavivirus Vaccines -- Application of Cleavage Activation Mutants of Influenza Virus as Live Vaccines -- Alphavirus Particle-based Vaccine Vectors -- Recombinant, Chimeric, Live, Attenuated Vaccines against Flaviviruses and Alphaviruses. 
520 |a Technological advances, together with a better understanding of the molecular biology of infectious microorganisms, are creating exciting possibilities for a new generation of replicating vaccines. Historically, live vaccines have been either directly derived from a natural source or attenuated by empirical approaches using serial passages and host cell adaptation. Currently, we are witnessing a quantum leap in our technological capabilities to specifically modify the genetic make-up of viruses and bacteria, making it possible to generate improved live vaccines and to develop completely new types of replicating vaccines, such as vectored vaccines, single-round infectious vaccines and replicon vaccines. This book highlights some of the most exciting recent developments towards a new generation of replicating vaccines. 
650 0 |a Medicine.  |0 http://id.loc.gov/authorities/subjects/sh85083064 
650 0 |a Immunology.  |0 http://id.loc.gov/authorities/subjects/sh85064579 
650 0 |a Medical microbiology.  |0 http://id.loc.gov/authorities/subjects/sh85082974 
650 0 |a Vaccines.  |0 http://id.loc.gov/authorities/subjects/sh85141718 
650 0 |a Virology.  |0 http://id.loc.gov/authorities/subjects/sh85143799 
650 1 4 |a Biomedicine. 
650 2 4 |a Medical Microbiology. 
650 2 4 |a Vaccine. 
650 2 4 |a Immunology. 
650 2 4 |a Virology. 
650 7 |a Medicine.  |2 fast  |0 (OCoLC)fst01014893 
650 7 |a Immunology.  |2 fast  |0 (OCoLC)fst00968006 
650 7 |a Medical microbiology.  |2 fast  |0 (OCoLC)fst01014362 
650 7 |a Vaccines.  |2 fast  |0 (OCoLC)fst01163573 
650 7 |a Virology.  |2 fast  |0 (OCoLC)fst01167670 
700 1 |a Dormitzer, Philip R.,  |e editor.  |0 http://id.loc.gov/authorities/names/n2011180816 
700 1 |a Mandl, Christian W.,  |e editor.  |0 http://id.loc.gov/authorities/names/n2011180817 
700 1 |a Rappuoli, Rino,  |e editor.  |0 http://id.loc.gov/authorities/names/n95800855 
740 0 |a Springer Biomedical and Life Sciences 
776 0 8 |i Printed edition:  |z 9783034602761 
830 0 |a Birkhäuser advances in infectious diseases.  |0 http://id.loc.gov/authorities/names/n2004017193 
856 4 0 |u https://dx.doi.org/10.1007/978-3-0346-0277-8  |z Connect to this title online  |t 0 
907 |a .b30757538  |b 240629  |c 170526 
998 |a uww  |b 170526  |c m  |d z   |e l  |f eng  |g sz   |h 0 
918 |a .bckstg  |b 2016-12-01 
919 |a .ulebk  |b 2017-02-14 
999 f f |i 2317e14f-08ec-597b-8ffa-41e1c3ab3c9a  |s bde76950-d840-5194-9329-a06ef22a480b  |t 0